
Sign up to save your podcasts
Or


Welcome to the third part of our Hope in the Pipeline series on hypersomnolence disorders. In this episode, we dive deep into:
🔹 Medications used to treat narcolepsy – from older stimulants to newer, longer-lasting options
🔹 The role of antidepressants and sodium oxybate in managing symptoms like cataplexy
🔹 Key differences between narcolepsy and idiopathic hypersomnia (IH)
🔹 Current treatment options for IH and why diagnosis can be so challenging
🔹 Exciting ongoing clinical research at Preferred Research Partners, including a new potential therapy targeting narcolepsy and IH
By Dr. Paul E. WylieWelcome to the third part of our Hope in the Pipeline series on hypersomnolence disorders. In this episode, we dive deep into:
🔹 Medications used to treat narcolepsy – from older stimulants to newer, longer-lasting options
🔹 The role of antidepressants and sodium oxybate in managing symptoms like cataplexy
🔹 Key differences between narcolepsy and idiopathic hypersomnia (IH)
🔹 Current treatment options for IH and why diagnosis can be so challenging
🔹 Exciting ongoing clinical research at Preferred Research Partners, including a new potential therapy targeting narcolepsy and IH